Stock UniverseDerived research view · source repositories remain read-only

NovaBridge Biosciences (NBP)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Watch
Selection Score
30.00
Global Rank
2009
Market Cap
378.15M
Latest Close
1.65
RS Composite
-54.47% · G#3301

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-26.89%
3M
-53.00%
6M
-57.27%
1Y
-8.10%
3Y
-46.94%
5Y
-97.97%
10Y
-86.84%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 598.13K · 30-day average: 1.03M · Max drawdown over stored range: -99.27%

Research Snapshot

Relative Strength vs SPX

RS Composite-54.47%
20D RS-26.54%
60D RS-57.89%
120D RS-65.03%
Global RS Rank3301 · 1.61% percentile
Watch+Speculative RS Rank2048 · 2.34% percentile
Group ScopeWatch+Speculative
Primary RS Rank439 · 4.15% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank303 / 701
Primary Percentile56.92
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for NBP.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue236.293813.8567-1.5510.6320
Revenue Growth (YoY)5384.301%-94.136%2600%2600%2600%
Gross Profit236.29386.5476-1.5510.6320
Operating Income23.829-326.0566-53.078-48.976-51.426
Free Cash Flow65.1824-157.892-92.315-146.664-106.675-20.604
Free Cash Flow Per Share0.953-2.079-1.119-1.762-1.314-0.215152
EPS (Diluted) GAAP1.056888-4.833454-4.496728-2.495909-0.273814
EPS Growth
EPS Non-GAAP
Gross Margin100%47.252%2600%100%2600%
Operating Margin10.084%-2353.063%2600%-7749.367%2600%
Profit Margin30.526%-2648.696%2600%-32868.513%2600%
Free Cash Flow Margin27.585%-1139.464%2600%-23206.329%2600%
Shares Outstanding (Diluted)68.361675.959682.516283.227881.186295.7648
Shares Change (YoY)2030.155%11.114%8.632%0.862%-2.453%17.957%

SEC Quarterly Fundamentals

No processed quarterly rows for NBP.